We are live on ! Find out more
TCA

Transcend Capital Advisors Portfolio holdings

AUM $1.25B
1-Year Est. Return 17.69%
This Fund
S&P 500
This Quarter Est. Return
+2.91%
1 Year Est. Return
+17.69%
3 Year Est. Return
+61.21%
5 Year Est. Return
+70.44%
10 Year Est. Return
AUM
$1.38B
AUM Growth
+$132M
Cap. Flow
+$110M
Cap. Flow %
7.96%
Top 10 Hldgs %
26.02%
Holding
618
New
82
Increased
295
Reduced
154
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 19.55%
2 Financials 16.04%
3 Healthcare 10.13%
4 Consumer Discretionary 4.67%
5 Communication Services 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KVUE icon
176
Kenvue
KVUE
$38.1B
$1.63M 0.12%
89,389
+1,094
+1% +$21.2K
CI icon
177
Cigna
CI
$80.2B
$1.62M 0.12%
4,890
+1,177
+32% +$406K
JEPQ icon
178
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$38.6B
$1.61M 0.12%
28,999
+357
+1% +$19.2K
JEPI icon
179
JPMorgan Equity Premium Income ETF
JEPI
$46B
$1.61M 0.12%
28,327
+854
+3% +$48.3K
VBK icon
180
Vanguard Small-Cap Growth ETF
VBK
$23.1B
$1.59M 0.12%
6,368
-231
-4% -$57.6K
LOW icon
181
Lowe's Companies
LOW
$122B
$1.58M 0.11%
7,186
-38
-0.5% -$8.67K
USMV icon
182
iShares MSCI USA Min Vol Factor ETF
USMV
$23.7B
$1.58M 0.11%
18,795
-1,420
-7% -$117K
APD icon
183
Air Products & Chemicals
APD
$65.8B
$1.57M 0.11%
6,085
+69
+1% +$17.5K
VZ icon
184
Verizon
VZ
$202B
$1.56M 0.11%
37,892
-457
-1% -$18.4K
CEG icon
185
Constellation Energy
CEG
$93B
$1.56M 0.11%
7,775
+2,030
+35% +$414K
BP icon
186
BP
BP
$108B
$1.55M 0.11%
43,064
+2,083
+5% +$78.1K
TGT icon
187
Target
TGT
$65.5B
$1.55M 0.11%
10,478
+475
+5% +$74.7K
FTAI icon
188
FTAI Aviation
FTAI
$21.5B
$1.55M 0.11%
14,993
ADC icon
189
Agree Realty
ADC
$9.71B
$1.55M 0.11%
24,964
+1,066
+4% +$63K
ASML icon
190
ASML
ASML
$607B
$1.54M 0.11%
1,505
+1,121
+292% +$1.08M
MMD
191
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
$282M
$1.52M 0.11%
91,781
-16,968
-16% -$276K
IYW icon
192
iShares US Technology ETF
IYW
$23.1B
$1.51M 0.11%
10,050
-187
-2% -$25.8K
IWM icon
193
iShares Russell 2000 ETF
IWM
$80.4B
$1.51M 0.11%
7,447
+1,532
+26% +$310K
IVE icon
194
iShares S&P 500 Value ETF
IVE
$49.6B
$1.51M 0.11%
8,280
-19
-0.2% -$3.46K
IBB icon
195
iShares Biotechnology ETF
IBB
$9.5B
$1.5M 0.11%
10,907
-83
-0.8% -$11.1K
IBIT icon
196
iShares Bitcoin Trust
IBIT
$47.2B
$1.49M 0.11%
+43,711
New +$1.63M
ET icon
197
Energy Transfer Partners
ET
$69.2B
$1.49M 0.11%
91,902
-4,797
-5% -$75.4K
COP icon
198
ConocoPhillips
COP
$139B
$1.48M 0.11%
12,944
+3,419
+36% +$415K
ISRG icon
199
Intuitive Surgical
ISRG
$131B
$1.47M 0.11%
3,315
+2,201
+198% +$877K
SCHZ icon
200
Schwab US Aggregate Bond ETF
SCHZ
$10.6B
$1.44M 0.1%
63,240
+7,314
+13% +$166K

Similar funds

Transcend Capital Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Transcend Capital Advisors held 618 positions worth $1.38B, up 11% from $1.25B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Transcend Capital Advisors deployed $110M of net new capital in Q2 2024, opening 82 new positions and adding to 295 existing holdings. Its largest new stake was Blue Owl Capital Corporation III: 577,763 shares worth $8.65M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Blue Owl Capital, an estimated $10.9M trimmed.

  • Transcend Capital Advisors's largest Q2 2024 buy was Blue Owl Capital Corporation III: 577,763 shares worth $8.65M.
  • Transcend Capital Advisors added most to AstraZeneca in Q2 2024, an estimated $4.24M increase.
  • Transcend Capital Advisors's biggest Q2 2024 reduction was Blue Owl Capital, cutting an estimated $10.9M.
  • Transcend Capital Advisors fully exited Crane Co in Q2 2024, selling an estimated $480K.
  • Transcend Capital Advisors's ten largest holdings make up 26% of its $1.38B portfolio in Q2 2024.
  • Transcend Capital Advisors opened 82 new positions and closed 21 in Q2 2024.
  • Transcend Capital Advisors's portfolio value rose 11% quarter-over-quarter to $1.38B.

Based on Transcend Capital Advisors's 13F filing for Q2 2024, filed 2 Jul 2024.